Lee D. Cranmer
City Of Hope National Medical Center · 272 works · 10,291 citations · h-index 42
Top works
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
- A randomized controlled comparison of pembrolizumab and chemotherapy in patients with ipilimumab-refractory melanoma
- Ipilimumab Granulomatous Interstitial Nephritis
- Double-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma: A Report From the 11715 Study Group
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma
- Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
- T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas
- Results of an International Randomized Phase III Trial of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus Versus Placebo to Control Metastatic Sarcomas in Patients After Benefit From Prior Chemotherapy
- Treatment of Unresectable and Metastatic Cutaneous Squamous Cell Carcinoma
- Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
- Skin Cancer Screening: Recommendations for Data-Driven Screening Guidelines and a review of the US Preventive Services Task Force Controversy
- Radiation-Induced Sarcoma of the Breast: A Systematic Review
- Angiosarcoma treated successfully with anti-PD-1 therapy - a case report
- nab -Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
- Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients
- Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
- Clinical applications of dendritic cell vaccination in the treatment of cancer